Eligibility, compliance and persistence of extended adjuvant endocrine therapy for breast cancer

Author： Myrick Mary E.   Schmid Seraina M.   Kilic Nerbil   Güth Uwe  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.51, Iss.2, 2012-02, pp. : 247-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant endocrine therapy in premenopausal women with breast cancer

By González Martín Antonio   Cruz Susana   Márquez Raúl  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-09 ,pp. : 43-47

Springer Publishing Company

Access to resources Recommend Favorite

Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment

By Niikura Naoki  

Breast Cancer, Vol. 20, Iss. 1, 2013-01 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant Endocrine Therapy for Early Breast Cancer: The Story So Far

By Gradishar William J.  

Cancer Investigation, Vol. 28, Iss. 4, 2010-04 ,pp. : 433-442

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Therapy of Breast Cancer

By Kaklamani Virginia   Gradishar William  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 548-560

Informa Healthcare

Access to resources Recommend Favorite

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer

By Sverrisdottir Asgerdur  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 755-763

Springer Publishing Company

Access to resources Recommend Favorite